Smithfield Trust CO Biogen Inc. Transaction History

Smithfield Trust CO

$1.89 Billion
Q1 2024

A detailed history of Smithfield Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 104 shares of BIIB stock, worth $23,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104

Previous 104 -0.0%

Holding current value

$23,359

Previous $27,000 18.52%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $2,019 - $2,453	-8 Reduced 7.14%	104 $30,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $5,197 - $7,823	-22 Reduced 16.42%	112 $27,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $1,323 - $1,528	5 Added 3.88%	134 $38,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $33,367 - $44,188	129 New	129 $35,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $12,543 - $17,331	-57 Closed	0 $0

Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $52,410 - $57,771	-239 Reduced 80.74%	57 $13,000
Q1 2019 Apr 30, 2019	BUY	$216.71 - $338.96 $64,146 - $100,332	296 New	296 $70,000
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $83,550 - $105,825	-300 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $6,163 - $8,060	-21 Reduced 6.54%	300 $106,000
Q2 2018 Jul 16, 2018	BUY	$257.52 - $306.91 $79,573 - $94,835	309 Added 2575.0%	321 $93,000
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $44,742 - $63,280	-172 Reduced 93.48%	12 $3,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $31,071 - $34,802	101 Added 121.69%	184 $58,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $23,335 - $27,364	83	83 $26,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Biogen Inc. Transaction History